Unlocking the Full Therapeutic Potential of mRNA
NovoVessel develops transformative mRNA technologies and therapeutics designed to address diseases that remain beyond the reach of conventional medicine.
THE CHALLENGE
The promise of mRNA is vast.
Its potential is not fully realized.
Many therapeutic applications remain limited by insufficient expression, poor tissue targeting, and high dosing requirements.
LIMITED EXPRESSION
Insufficient protein production limited therapeutic potential
POOR SELECTIVITY
Off-target expression can reduce efficacy and increase risk.
HIGH DOSE EFFICIENCY
Many mRNA therapies require higher doses to achieve effect.
We are pioneering the technologies to cure diseases, not just manage symptoms.
NovoVessel is building the next generation of mRNA technologies and regenerative therapeutics to restore biological function and transform the treatment of serious diseases.
RESTORE BLOOD FLOW
Rebuild healthy vasculature to deliver oxygen and nutrients.
REGENERATIVE TISSUE
Activate the body’s natural ability to repair and rebuild.
RECOVER FUNCTION
Go beyond symptom management to restore quality of life.
SCIENTIFIC LEADERSHIP
Lior Zangi, PhD
Co-Founder & Chief Scientific Officer
Pioneer in mRNA-based regenerative medicine and internationally recoginzed leader in cardiovascular biology.
PARTNER WITH US
Together, we can transform medicine.
We are actively seeking strategic partners to co-develop and bring the next generation of mRNA medicines to patients.